Launched in March 2017 as part of the Innovative Medicines Initiative 2 (IMI2), BigData@Heart is developing a Big Data-driven translational research platform of unparalleled scale and resolution. This will provide clinically relevant and scalable insights from real-world evidence, driving drug development and personalised medicine through advanced analytics. 

Please follow the link for more information.

Speakers:

  Dr Maureen Cronin
  Big Data @Heart co-Lead
  Chief Medical Officer
  Ava AG

 

 

 Prof Hester den Ruijter
 Professor of Cardiovascular disease in women
 University Medical Center Utrecht
 

 

 

 Ms Peggy Maguire
 Director General
 European Institute of Women's Healthv

 

 

 

 Dr Megan Molnar
 Epidemiologist
 Bayer
 (Moderator)